Search

Your search keyword '"Jack, Kellie"' showing total 7 results
Start Over Author "Jack, Kellie"
7 results on '"Jack, Kellie"'

3. Engaging Underrepresented Patients in Hematology Clinical Trials through the LLS Impact (Influential Medicine Providing Access to Clinical Trials) Research Grant: A Multi-Institutional Effort

Author

Biltibo, Eden Ayele, Copeland, Zachary, Nelson, Erik, Logan, Nina, Jack, Kellie, Johnston, Jamie, Leautaud, Veronica, Philip, Lammers, Goorha, Salil, Randolph, Brion, Cohen, Jonathon B., Kives, Melissa, Yaffe, Michael, Greenberger, Lee M., Flowers, Christopher R., Siddiqi, Tanya, Smith, Clayton, Phillips, Erica, Leonard, John P., Nowakowski, Grzegorz S., and Savona, Michael R.

Published
2023
Full Text
View/download PDF

4. Abstract PO-034: A collaborative approach to increase germline testing and counseling uptake within New York City’s underserved patient population

Author

Vado, Kenya P., primary, Reynolds, Thomas, additional, Jack, Kellie, additional, Bulone, Linda, additional, Kemeny, Margaret, additional, Gonsky, Jason, additional, Kampel, Lewis, additional, Mcmillan, Shadai, additional, Maio, Anna, additional, Sheehan, Margaret, additional, Salo-Mullen, Erin, additional, Naupari, Sandy, additional, Galle, Jesse, additional, Williams, Alisha, additional, Stadler, Zsofia, additional, Robson, Mark, additional, Solit, David, additional, Sabbatini, Paul, additional, and Brown, Carol, additional

Published
2020
Full Text
View/download PDF

5. Abstract A090: Community partnerships expand access to tumor molecular profiling

Author

Reynolds, Thomas, primary, Jack, Kellie, additional, Kemeny, Margaret, additional, Bulone, Linda, additional, Gonsky, Jason, additional, Kampel, Lewis J., additional, Hyman, David, additional, Solit, David B., additional, Conklin, Claire, additional, McMillan, Shadai, additional, DeSimone, Nicole, additional, Galle, Jesse, additional, Naupari, Sandy, additional, and Brown, Carol L., additional

Published
2020
Full Text
View/download PDF

6. Phase II study of gemcitabine (G), trastuzumab (H), and pertuzumab (P) for HER2-positive metastatic breast cancer (MBC) after prior pertuzumab-based therapy.

Author

Iyengar, Neil M., primary, Smyth, Lillian Mary, additional, Lake, Diana, additional, Gucalp, Ayca, additional, Singh, Jasmeet Chadha, additional, Traina, Tiffany A., additional, DeFusco, Patricia Anne, additional, Dickler, Maura N., additional, Fornier, Monica N., additional, Goldfarb, Shari Beth, additional, Jhaveri, Komal L., additional, Modi, Shanu, additional, Troso-Sandoval, Tiffany A., additional, Jack, Kellie, additional, Ulaner, Gary, additional, Jochelson, Maxine S., additional, Baselga, Jose, additional, Norton, Larry, additional, Hudis, Clifford A., additional, and Dang, Chau T., additional

Published
2017
Full Text
View/download PDF

7. Phase II study of gemcitabine (G), trastuzumab (H), and pertuzumab (P) for HER2-Positive metastatic breast cancer (MBC) after prior HP- or TDM/P-based therapy.

Author

Iyengar, Neil M., primary, Smyth, Lillian Mary, additional, Jochelson, Maxine S., additional, Lake, Diana, additional, Gucalp, Ayca, additional, Dickler, Maura N., additional, Goldfarb, Shari Beth, additional, Latif, Asma, additional, Modi, Shanu, additional, Singh, Jasmeet Chadha, additional, Traina, Tiffany A., additional, Troso-Sandoval, Tiffany A., additional, Ulaner, Gary, additional, Argolo, Daniel F., additional, Jack, Kellie, additional, Lichtenauer, Daniel, additional, Baselga, Jose, additional, Norton, Larry, additional, Hudis, Clifford A., additional, and Dang, Chau T., additional

Published
2016
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results